Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

470 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.
Molyneux PD, Kappos L, Polman C, Pozzilli C, Barkhof F, Filippi M, Yousry T, Hahn D, Wagner K, Ghazi M, Beckmann K, Dahlke F, Losseff N, Barker GJ, Thompson AJ, Miller DH. Molyneux PD, et al. Brain. 2000 Nov;123 ( Pt 11):2256-63. doi: 10.1093/brain/123.11.2256. Brain. 2000. PMID: 11050025 Clinical Trial.
Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS.
Molyneux PD, Barker GJ, Barkhof F, Beckmann K, Dahlke F, Filippi M, Ghazi M, Hahn D, MacManus D, Polman C, Pozzilli C, Kappos L, Thompson AJ, Wagner K, Yousry T, Miller DH; European Study Group on Interferon Beta-1b in Secondary Progressive MS. Molyneux PD, et al. Neurology. 2001 Dec 26;57(12):2191-7. doi: 10.1212/wnl.57.12.2191. Neurology. 2001. PMID: 11756596 Clinical Trial.
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study.
Wegner C, Filippi M, Korteweg T, Beckmann C, Ciccarelli O, De Stefano N, Enzinger C, Fazekas F, Agosta F, Gass A, Hirsch J, Johansen-Berg H, Kappos L, Barkhof F, Polman C, Mancini L, Manfredonia F, Marino S, Miller DH, Montalban X, Palace J, Rocca M, Ropele S, Rovira A, Smith S, Thompson A, Thornton J, Yousry T, Matthews PM. Wegner C, et al. Eur J Neurol. 2008 Feb;15(2):113-22. doi: 10.1111/j.1468-1331.2007.02027.x. Eur J Neurol. 2008. PMID: 18217881
MRI criteria for MS in patients with clinically isolated syndromes.
Montalban X, Tintoré M, Swanton J, Barkhof F, Fazekas F, Filippi M, Frederiksen J, Kappos L, Palace J, Polman C, Rovaris M, de Stefano N, Thompson A, Yousry T, Rovira A, Miller DH. Montalban X, et al. Neurology. 2010 Feb 2;74(5):427-34. doi: 10.1212/WNL.0b013e3181cec45c. Epub 2010 Jan 6. Neurology. 2010. PMID: 20054006
T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.
Bodini B, Battaglini M, De Stefano N, Khaleeli Z, Barkhof F, Chard D, Filippi M, Montalban X, Polman C, Rovaris M, Rovira A, Samson R, Miller D, Thompson A, Ciccarelli O. Bodini B, et al. J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):72-7. doi: 10.1136/jnnp.2009.201574. Epub 2010 Jul 13. J Neurol Neurosurg Psychiatry. 2011. PMID: 20627965 Free PMC article.
470 results